NTRK Fusion Testing

NTRK Fusion Testing

NTRK gene fusions can drive unregulated cell growth and proliferation in a range of cancer types. Recently, this pathway gained significant focus and attention in precision oncology.

Next-Generation Sequencing provides the most comprehensive view across a large number of genes and can identify NTRK gene fusions as well as other relevant alterations, with minimal sample tissue needed.

Introduction to NTRK Testing in 3 minutes – Download the Quick Reference guide

• Discover the key factors for NTRK fusion testing
• Compare different testing methods for NTRK fusions
• Learn how to get started with NGS for NTRK testing
• Find the right solution to meet your needs

Get the Guide

Webinar: NTRK Fusion Testing in Lung Cancer

View this educational webinar to learn:

Why NTRK fusion testing is becoming important.
Different methods of NTRK fusion detection, including their pros and cons based on real data from lung cancer testing.
How developments in precision oncology are changing not only cancer care, but also the way we should approach biomarker testing in our laboratories.

Speaker:
PD Dr. med. Spasenija Savic Prince
Attending Pathologist
Institute for Medical Genetics and Pathology, University Hospital Basel, Switzerland

Learn more about Oncomine Solutions

We offer several NGS-based, multibiomarker assays for clinical research designed to simultaneously detect gene fusions, such as NTRK1, NTRK2 and NTRK3, as well as hundreds of DNA and RNA-based genomic alterations associated with cancer. They include: Oncomine Precision Assay, Oncomine Comprehensive Assay, Oncomine Focus Assay, and Oncomine Childhood Cancer Research Assay.

Explore Oncomine Solutions

For Research Use Only. Not for use in diagnostic procedures.

NTRK Fusion Testing